NDC 53002-9450

Ciclopirox Olamine

Ciclopirox Olamine

Ciclopirox Olamine is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Rpk Pharmaceuticals, Inc.. The primary component is Ciclopirox Olamine.

Product ID53002-9450_6d53dfb7-21e4-4fce-8b1c-81914912eab7
NDC53002-9450
Product TypeHuman Prescription Drug
Proprietary NameCiclopirox Olamine
Generic NameCiclopirox Olamine
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2005-04-12
Marketing CategoryANDA / ANDA
Application NumberANDA076790
Labeler NameRPK Pharmaceuticals, Inc.
Substance NameCICLOPIROX OLAMINE
Active Ingredient Strength8 mg/g
Pharm ClassesDecreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 53002-9450-1

30 g in 1 TUBE (53002-9450-1)
Marketing Start Date2018-10-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53002-9450-2 [53002945002]

Ciclopirox Olamine CREAM
Marketing CategoryANDA
Application NumberANDA076790
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-10-01
Inactivation Date2020-01-31

NDC 53002-9450-1 [53002945001]

Ciclopirox Olamine CREAM
Marketing CategoryANDA
Application NumberANDA076790
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-10-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
CICLOPIROX OLAMINE7.7 mg/g

OpenFDA Data

SPL SET ID:92bb2354-5592-4f16-b193-f34306d7bc39
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309289
  • Pharmacological Class

    • Decreased DNA Replication [PE]
    • Decreased Protein Synthesis [PE]
    • Decreased RNA Replication [PE]
    • Protein Synthesis Inhibitors [MoA]

    NDC Crossover Matching brand name "Ciclopirox Olamine" or generic name "Ciclopirox Olamine"

    NDCBrand NameGeneric Name
    0168-0313ciclopirox olamineciclopirox olamine
    0713-0638Ciclopirox OlamineCiclopirox Olamine
    45802-138Ciclopirox OlamineCiclopirox Olamine
    45802-400Ciclopirox OlamineCiclopirox Olamine
    49999-646CICLOPIROX OLAMINECICLOPIROX OLAMINE
    51672-1318Ciclopirox Olamineciclopirox olamine
    53002-9450Ciclopirox Olamineciclopirox olamine
    63629-2522Ciclopirox OlamineCiclopirox Olamine
    63629-8624Ciclopirox OlamineCiclopirox Olamine
    63629-8625Ciclopirox OlamineCiclopirox Olamine
    63629-8626Ciclopirox OlamineCiclopirox Olamine
    63629-8627Ciclopirox OlamineCiclopirox Olamine
    68071-1608Ciclopirox OlamineCiclopirox Olamine
    68071-4162Ciclopirox Olamineciclopirox olamine
    68258-3996Ciclopirox OlamineCiclopirox Olamine
    68462-297Ciclopirox OlamineCiclopirox Olamine
    69315-309CICLOPIROX OLAMINECICLOPIROX OLAMINE
    80425-0225Ciclopirox OlamineCiclopirox Olamine
    43538-540Loproxciclopirox olamine
    43538-541LoproxCiclopirox Olamine
    43538-550Loproxciclopirox olamine
    43538-551LoproxCiclopirox Olamine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.